STEVEN MICHAEL LAMIE

Allopathic & Osteopathic Physicians|Internal Medicine TRAVERSE CITY, MI NPI 1013909217

General Payments — all program years on this page

$75,049.24

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 271
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $412.08 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $412.0820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $21,504.5769
2019 $41,461.9281
2020 $8,455.3937
2021 $2,340.9614
2022 $401.2825
2023 $473.0425
2024 $412.0820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078054618 Janssen Pharmaceuticals, Inc $15.38 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089446348 Daiichi Sankyo Inc. $24.27 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096859966 Novo Nordisk Inc $14.57 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097354806 Novo Nordisk Inc $22.95 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101699152 E.R. Squibb & Sons, L.L.C. $13.12 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104133044 ABBVIE INC. $26.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104133046 ABBVIE INC. $13.72 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104212477 AstraZeneca Pharmaceuticals LP $19.37 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105307101 AstraZeneca Pharmaceuticals LP $18.21 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105686651 AstraZeneca Pharmaceuticals LP $18.02 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115847631 Amgen Inc. $29.87 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115847642 Amgen Inc. $20.37 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131057246 PFIZER INC. $13.29 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131162766 PFIZER INC. $15.88 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135350942 Lilly USA, LLC $24.21 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135432961 Lilly USA, LLC $19.28 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135433157 Lilly USA, LLC $19.42 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139397423 Astellas Pharma US Inc $13.38 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148071223 Inspire Medical Systems, Inc. $47.42 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153338545 Dexcom, Inc. $23.14 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.